UK: A recent retrospective cohort study has highlighted the critical role of kidney function in patients diagnosed with ...

Research found that younger age at type 2 diabetes diagnosis is associated with higher risks of cardiovascular and all-cause ...

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...

Some 20% to 30% of gout patients also have CKD, the researchers said, which is not surprising since they share many risk ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...

Detailed price information for Lexicon Pharmaceutcl (LXRX-Q) from The Globe and Mail including charting and trades.

Despite clinician concerns, treating patients with gout and stage 3 chronic kidney disease (CKD) with urate-lowering therapy does not appear to ... 11% lower relative risk of kidney function decline ...

Researchers recently collaborated on a novel, highly specific strategy to treat type 1 diabetes (T1D) using a tagged beta cell transplant in tandem with localized immune protection provided by ...

Studies investigating what is damaging the kidney in lupus nephritis point to tubulointerstitial inflammation.

Discover how kidney function decline in ATTR-CM patients predicts higher mortality, highlighting its role as a critical marker in disease management and care optimisation.